135 related articles for article (PubMed ID: 11136779)
21. [Application of nucleic acid sequence-based amplification in detection of cytomegalovirus mRNA of recipients after allogeneic peripheral blood stem cell transplantation].
Xu HX; Liu YF; Tan EX; Cai JT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1195-9. PubMed ID: 17204193
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of US28 gene expression during active human cytomegalovirus infection in lung-transplant recipients.
Boomker JM; Verschuuren EA; Brinker MG; de Leij LF; The TH; Harmsen MC
J Infect Dis; 2006 Jun; 193(11):1552-6. PubMed ID: 16652284
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages.
Keightley MC; Rinaldo C; Bullotta A; Dauber J; St George K
J Clin Virol; 2006 Dec; 37(4):258-64. PubMed ID: 16978918
[TBL] [Abstract][Full Text] [Related]
24. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
Meyer T; Reischl U; Wolf H; Schüller C; Arndt R
Mol Cell Probes; 1994 Aug; 8(4):261-71. PubMed ID: 7870068
[TBL] [Abstract][Full Text] [Related]
25. The pp67 mRNA assay in treatment and monitoring of cytomegalovirus disease in renal transplant patients in India.
Wattal C; Joshi S; Gupta A; Sharma A; Oberoi JK; Prasad KJ; Rana DS; Bhalla A; Khullar D
Transpl Infect Dis; 2004 Jun; 6(2):90-2. PubMed ID: 15522113
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
[TBL] [Abstract][Full Text] [Related]
27. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
[TBL] [Abstract][Full Text] [Related]
28. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
Lam KM; Oldenburg N; Khan MA; Gaylore V; Mikhail GW; Strouhal PD; Middeldorp JM; Banner N; Yacoub M
J Heart Lung Transplant; 1998 Jun; 17(6):555-65. PubMed ID: 9662090
[TBL] [Abstract][Full Text] [Related]
29. Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification.
Blok MJ; Christiaans MH; Goossens VJ; van Hooff JP; Sillekens P; Middeldorp JM; Bruggeman CA
Transplantation; 1999 May; 67(9):1274-7. PubMed ID: 10342321
[TBL] [Abstract][Full Text] [Related]
30. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
Blank BS; Meenhorst PL; Mulder JW; Weverling GJ; Putter H; Pauw W; van Dijk WC; Smits P; Lie-A-Ling S; Reiss P; Lange JM
J Clin Microbiol; 2000 Feb; 38(2):563-9. PubMed ID: 10655346
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients.
Meyer-König U; Serr A; von Laer D; Kirste G; Wolff C; Haller O; Neumann-Haefelin D; Hufert FT
J Infect Dis; 1995 Mar; 171(3):705-9. PubMed ID: 7876623
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
[TBL] [Abstract][Full Text] [Related]
33. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients.
Kulkarni A; Westmoreland D; Fox JD
Clin Microbiol Infect; 2001 Apr; 7(4):179-86. PubMed ID: 11422239
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
35. Prevention of CMV disease in pediatric kidney transplant recipients: evaluation of pp67 NASBA-based pre-emptive ganciclovir therapy combined with CMV hyperimmune globulin prophylaxis in high-risk patients.
Renoult E; Clermont MJ; Phan V; Buteau C; Alfieri C; Tapiero B
Pediatr Transplant; 2008 Jun; 12(4):420-5. PubMed ID: 18466427
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of reverse transcription-PCR for detection of cytomegalovirus pp67 in samples from solid-organ transplant recipients.
Meyer-Koenig U; Romberg I; Schneider K; Weidmann M; Kern WV; Hufert FT
J Clin Microbiol; 2006 Sep; 44(9):3394-6. PubMed ID: 16954283
[TBL] [Abstract][Full Text] [Related]
38. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
[TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial.
Gerna G; Lilleri D; Baldanti F; Torsellini M; Giorgiani G; Zecca M; De Stefano P; Middeldorp J; Locatelli F; Revello MG
Blood; 2003 Jun; 101(12):5053-60. PubMed ID: 12586622
[TBL] [Abstract][Full Text] [Related]
40. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
